Human Reproduction, Vol. 17, No. 3, 625-633,
March 2002
© 2002 European Society of Human Reproduction and Embryology
Predicting pregnancy and spermatogenesis by survival analysis during gonadotrophin treatment of gonadotrophin-deficient infertile men
1 Department of Andrology and ANZAC Research Institute, Concord Hospital, and 2 NHMRC Clinical Trials Centre, University of Sydney, Sydney NSW 2139, Australia
BACKGROUND: Predictors of fertility or spermatogenesis during gonadotrophin therapy of gonadotrophin-deficient men remain poorly defined. METHODS AND RESULTS: In order to evaluate potential predictors, this study evaluated 29 consecutive gonadotrophin-deficient men all desiring paternity who received 43 courses of therapy in one centre between 1982 and 1998. The Kaplan–Meier survival analysis estimates of median (SE) time to a sperm concentration of >0, >5 and >20x106/ml were 5.5 (1.1), 12.4 (2.3) and 29.1 (1.9) months respectively. Conception occurred in 22/43 cycles (with eight men achieving two pregnancies) with a median (SE) Kaplan–Meier estimate of 20.5 (4.7) months. The median sperm concentration at conception was 5.0 (SE 2.0; range 0.0–59.5) x106/ml. Multivariate correlated Cox proportional hazards models predicting these same sperm thresholds and conception were developed by forward stepwise variable selection with verification of the model by backward stepping. Larger testicular volume, prior gonadotrophin therapy, completion of puberty, older age, the absence of adverse fertility factors and the absence of multiple pituitary hormone deficiency predicted a favourable response. Multivariate modelling suggests that the two most important predictors of sperm output are testicular volume and pubertal status. The most important potentially modifiable predictor was prior gonadotrophin therapy. The efficacy of recombinant and urinary FSH were similar. Prior androgen therapy and partner's age did not appear to be significant. CONCLUSIONS: Since prolonged treatment may be required to induce spermatogenesis, attention to these predictors may allow appropriate early use of advanced reproductive technologies.
Key words: gonadotrophin deficiency/gonadotrophin therapy/men/survival analysis
3 To whom correspondence should be addressed at: ANZAC Research Institute, Sydney, NSW 2139, Australia. E-mail: djh{at}med.usyd.edu.au
Submitted on May 10, 2001; resubmitted on September 21, 2001
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  P. Y. Liu, H. W. G. Baker, V. Jayadev, M. Zacharin, A. J. Conway, and D. J. Handelsman Induction of Spermatogenesis and Fertility during Gonadotropin Treatment of Gonadotropin-Deficient Infertile Men: Predictors of Fertility Outcome J. Clin. Endocrinol. Metab., March 1, 2009; 94(3): 801 - 808. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Madhukar and S. Rajender Hormonal Treatment of Male Infertility: Promises and Pitfalls J Androl, March 1, 2009; 30(2): 95 - 112. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Bhasin Approach to the Infertile Man J. Clin. Endocrinol. Metab., June 1, 2007; 92(6): 1995 - 2004. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. J. Handelsman The Rationale for Banning Human Chorionic Gonadotropin and Estrogen Blockers in Sport J. Clin. Endocrinol. Metab., May 1, 2006; 91(5): 1646 - 1653. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P.-M. G. Bouloux, E. Nieschlag, H. G. Burger, N. E. Skakkebaek, F. C.W. Wu, D. J. Handelsman, G. H.W. Baker, R. Ochsenkuehn, A. Syska, R. I. Mclachlan, et al. Induction of Spermatogenesis by Recombinant Follicle-Stimulating Hormone (Puregon) in Hypogonadotropic Azoospermic Men Who Failed to Respond to Human Chorionic Gonadotropin Alone J Androl, July 1, 2003; 24(4): 604 - 611. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Haywood, J. Spaliviero, M. Jimemez, N. J. C. King, D. J. Handelsman, and C. M. Allan Sertoli and Germ Cell Development in Hypogonadal (hpg) Mice Expressing Transgenic Follicle-Stimulating Hormone Alone or in Combination with Testosterone Endocrinology, February 1, 2003; 144(2): 509 - 517. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. J. Handelsman Optimal Power Transformations for Analysis of Sperm Concentration and Other Semen Variables J Androl, September 1, 2002; 23(5): 629 - 634. [Abstract] [Full Text] [PDF]
|
|